Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))

Swati Bhattacharyya

doi:10.1016/j.ajpath.2011.05.007

Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))

Swati Bhattacharyya^*

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	537
Number of pages	1
Journal	American Journal of Pathology
Volume	179
Issue number	1
DOIs	https://doi.org/10.1016/j.ajpath.2011.05.007
State	Published - Jul 2011

ASJC Scopus subject areas

Pathology and Forensic Medicine

Access to Document

10.1016/j.ajpath.2011.05.007

Cite this

Bhattacharyya, S. (2011). Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090)). American Journal of Pathology, 179(1), 537. https://doi.org/10.1016/j.ajpath.2011.05.007

@article{3e39e71f5a0d480eb05611a93907e077,

title = "Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))",

author = "Swati Bhattacharyya",

year = "2011",

month = jul,

doi = "10.1016/j.ajpath.2011.05.007",

language = "English (US)",

volume = "179",

pages = "537",

journal = "American Journal of Pathology",

issn = "0002-9440",

publisher = "Elsevier Inc.",

number = "1",

}

Bhattacharyya, S 2011, 'Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))', American Journal of Pathology, vol. 179, no. 1, pp. 537. https://doi.org/10.1016/j.ajpath.2011.05.007

Erratum : The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090)). / Bhattacharyya, Swati.

In: American Journal of Pathology, Vol. 179, No. 1, 07.2011, p. 537.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))

AU - Bhattacharyya, Swati

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=80052442630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052442630&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.05.007

DO - 10.1016/j.ajpath.2011.05.007

M3 - Comment/debate

AN - SCOPUS:80052442630

SN - 0002-9440

VL - 179

SP - 537

JO - American Journal of Pathology

JF - American Journal of Pathology

IS - 1

ER -

Erratum: The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses (American Journal of Pathology (2011) 178 (2077-2090))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this